KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Acquisitions (2016 - 2025)

Historic Acquisitions for Resmed (RMD) over the last 16 years, with Q3 2025 value amounting to $522000.0.

  • Resmed's Acquisitions fell 3894.74% to $522000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $139.1 million, marking a year-over-year increase of 47240.44%. This contributed to the annual value of $140.1 million for FY2025, which is 396.71% up from last year.
  • According to the latest figures from Q3 2025, Resmed's Acquisitions is $522000.0, which was down 3894.74% from $138.6 million recorded in Q2 2025.
  • Resmed's 5-year Acquisitions high stood at $992.1 million for Q4 2022, and its period low was $522000.0 during Q3 2025.
  • For the 5-year period, Resmed's Acquisitions averaged around $91.8 million, with its median value being $8.4 million (2021).
  • In the last 5 years, Resmed's Acquisitions soared by 266242.52% in 2022 and then plummeted by 9924.35% in 2023.
  • Quarter analysis of 5 years shows Resmed's Acquisitions stood at $35.9 million in 2021, then surged by 2662.43% to $992.1 million in 2022, then plummeted by 99.24% to $7.5 million in 2023, then crashed by 91.07% to $670000.0 in 2024, then dropped by 22.09% to $522000.0 in 2025.
  • Its Acquisitions was $522000.0 in Q3 2025, compared to $138.6 million in Q2 2025 and $670000.0 in Q4 2024.